Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 298, 82-89
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Italiana Sclerosi Multipla (2009/R/8)
This publication has 44 references indexed in Scilit:
- Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective studyJournal of Neurology, 2013
- Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald CriteriaISRN Neurology, 2012
- Modulation of Immune Cell Function by α1-Adrenergic Receptor Activation2011
- A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple SclerosisArchives of Neurology, 2010
- The immunoregulatory role of dopamine: An updateBrain, Behavior, and Immunity, 2010
- Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosisExperimental Neurology, 2008
- The role of regulatory T cells in multiple sclerosisNature Clinical Practice Neurology, 2008
- Dopamine Fails to Regulate Activation of Peripheral Blood Lymphocytes from Multiple Sclerosis Patients: Effects of IFN-βJournal of Interferon & Cytokine Research, 2005
- The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritisBrain, Behavior, and Immunity, 2004
- Rating neurologic impairment in multiple sclerosisNeurology, 1983